Physician profile
Jonathan Yun
NPI 1467771279
$9,007.63
in general payments reported to CMS, 2019-2025
21 companies · $993 in 2025
The $993 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.34 · 2020: $119 · 2021: $344 · 2022: $3,122 · 2023: $3,000 · 2024: $1,372 · 2025: $993.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,067 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,125 · Travel and Lodging: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,066.60 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,125.00 |
| Travel and Lodging | $173.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viseon, INC. | $3,960.60 | 2022-2024 | Maxview System - Lateral Set |
| Abbott Laboratories | $1,980.45 | 2019-2025 | Proclaim, Eterna |
| Providence Medical Technology, INC. | $577.54 | 2024-2025 | |
| Medtronic, INC. | $560.02 | 2022-2025 | Stealthstation S8 Platform, Intellis Adaptivestim |
| Stryker Corporation | $424.43 | 2022-2023 | Core, Tritanium |
| Globus Medical, INC. | $277.44 | 2025 | Autobahn, Senza |
| Biotronik Nro, INC. | $196.03 | 2024-2025 | Prospera |
| Nuvasive, INC. | $168.42 | 2021-2022 | |
| Mml US, INC. | $124.45 | 2024 | Reactiv8 |
| Si-Bone, INC. | $119.62 | 2023 | |
| Boston Scientific Corporation | $114.31 | 2021 | |
| Djo, LLC | $105.03 | 2024 | Cmf |
| Choice Spine, LLC | $104.10 | 2020 | |
| Saluda Medical Americas, INC. | $62.26 | 2023 | Evoke Scs |
| Alphatec Spine, INC | $55.32 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ossdsign USA Incorporated | $53.96 | 2025 | Ossdsign Catalyst |
| Theragen, INC. | $34.71 | 2024-2025 | Actastim-S |
| Ethicon US, LLC | $30.76 | 2024 | Surgiflo Hemostatic Matrix |
| Zimvie INC. | $24.50 | 2022 | |
| Intrinsic Therapeutics | $18.95 | 2021 | |
| Medtronic USA, INC. | $14.73 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$91,311.79 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Yun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.